Hematoma Block for Reduction of Distal Radius Fractures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2018-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to Prove that injection of 15 to 20 mL of lidocaine 1% into the fracture site (Hematoma block) is more effective in terms of pain relieving then injection of 10 mL of lidocaine 2%, and equally safe in terms of complications, for closed reduction of distal radius fractures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Nerve and Hematoma Blocks for Pain Relief During Distal Radius Fracture Reduction

NCT07183904

Acute Distal Radius Fracture Displaced Distal Radius Fracture

COMPLETED NA

Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction

NCT00763880

Forearm Fracture

TERMINATED PHASE4

Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures

NCT06379490

Distal Radius Fractures Lidocaine Ropivacaine +3 more

COMPLETED PHASE3

Wrist Reduction Intervention: Supracondylar Technique for Radial Nerve Block vs. Hematoma Block (WRIST Block Study)

NCT07268547

Wrist Fracture

ENROLLING_BY_INVITATION PHASE4

Ultrasound Guided Hematoma Block in Distal Radius Fractures

NCT06193915

Distal Radius Fractures Fracture Dislocation Dislocated Wrist +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fractures of the Distal Radius

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lidocaine HCl 2%

Lidocaine HCl 2% (200mg/10ml) 10 ml.

Group Type ACTIVE_COMPARATOR

Lidocaine HCl 2% .

Intervention Type DRUG

comparison of different dosages of drug

Lidocaine HCl 1%

Lidocaine HCl 1% (100mg/10ml) 15-20 ml.

Group Type EXPERIMENTAL

Lidocaine HCl 1%

Intervention Type DRUG

comparison of different dosages of drug

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lidocaine HCl 2% .

comparison of different dosages of drug

Intervention Type DRUG

Lidocaine HCl 1%

comparison of different dosages of drug

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ESRACAIN ESRACAIN

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Fractures of the distal radius, with or without ulna fracture

Exclusion Criteria

* Children,
* pregnant women,
* patients with infection or suspected infection on the site for injection.
* Patients whose condition requires general anesthesia (patients with more fractures other than the distal radius and ulna, patients with many damage...)

Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No